Using a Risk-Based Approach to Manufacturing in a Multi-Product FacilityBy Baxter BioPharma Solutions
Manufacturing in multi-product facilities affords numerous advantages but also presents significant challenges. At its Halle / Westfalen, Germany, plant, Baxter BioPharma Solutions has implemented a risk-based approach to addressing those challenges, providing customers with the benefits of multiproduct manufacturing. The biopharmaceutical industry is continually challenged to reduce costs and the time needed to produce advanced drug products. Drug manufacturers are consequently pursuing numerous approaches to achieving gains in efficiency and productivity.